Home › Mga Employer › Canaccord Genuity LLC
Canaccord Genuity LLC: Mga sahod ng H-1B at sponsorship
Isinampa ng Canaccord Genuity LLC ang 22 labor condition applications para sa H-1B at kaugnay na visa sa mga fiscal year na 2023–2026; sertipikado: 22. Median offered salary: $135,000.
Nag-sponsor ba ang Canaccord Genuity LLC ng mga visa na H-1B?
Isinampa ng Canaccord Genuity LLC ang 22 labor condition applications sa mga fiscal year na 2023–2026, ang pinakabago ay isinampa noong May 13, 2026. Ang LCA ay ang unang hakbang ng isang petisyong H-1B, kaya ang employer ay nag-sponsor o naghanda na mag-sponsor ng mga manggagawang H-1B; hindi nito ginagarantiyahan ang sponsorship para sa anumang partikular na trabaho. Tingnan ang sariling listahan ng trabaho ng employer.
Mga sahod ayon sa titulo ng trabaho
| Titulo ng Trabaho | LCAs | Median na sahod |
|---|---|---|
| Investment Banking Analyst | 3 | $100,000 |
| Associate, Australian Desk Salesperson | 2 | $110,000 |
| Banking Analyst 1 | 2 | $100,000 |
| Director, Investment Banking | 1 | $250,000 |
| Senior Research Associate (Biotechnology) | 1 | $135,000 |
| Analyst (2nd Year) | 1 | $105,000 |
| Analyst (3rd Year) | 1 | $120,000 |
| Director, Australian Equities | 1 | $175,000 |
| Director, Salesperson | 1 | $120,000 |
| Vice President - Australian Product Sales | 1 | $145,000 |
| Australian Institutional Equity Sales (Americas) | 1 | $188,880 |
| Banking Analyst 2 | 1 | $110,000 |
| Second Year Banking Associate | 1 | $180,000 |
| Vice President, Biotechnology Equity Research | 1 | $150,000 |
| Managing Director, Australian Equity Sales Manager | 1 | $175,000 |
| Managing Director, Australian Equity Sales - Americas | 1 | $175,000 |
| Investment Banking Associate 2 | 1 | $180,000 |
| VP, Biotechnology Equity Research | 1 | $150,000 |
Mga aplikasyon ayon sa fiscal year
| Piskal na taon | LCAs | Median na sahod |
|---|---|---|
| FY2023 | 9 | $110,000 |
| FY2024 | 2 | $147,500 |
| FY2025 | 7 | $145,000 |
| FY2026 | 4 | $175,000 |
Antas ng prevailing wage
- Antas I (pasukan)36%
- Antas II (kwalipikado)32%
- Antas III (may karanasan)27%
- Antas IV (ganap na kompetente)5%
Itinakda ng Department of Labor ang apat na antas ng prevailing wage para sa bawat okupasyon at lugar, mula Level I (entry) hanggang Level IV (fully competent). Pinipili ng employer ang antas na tumutugma sa mga kinakailangan ng trabaho.
Kung saan naroroon ang mga trabaho
Mga Okupasyon
- Financial and Investment Analysts10
- Securities, Commodities, and Financial Services Sales Agents8
- Statisticians3
- Financial Managers1
Pinakabagong aplikasyon
| Titulo ng Trabaho | Batayang sahod | Lokasyon | Isumite | Petsa ng Simula | Status |
|---|---|---|---|---|---|
| VP, Biotechnology Equity Research | $150,000 Antas III | New York, NY | May 13, 2026 | Okt 1, 2026 | Sertipikado |
| Investment Banking Associate 2 | $180,000 Antas IV | New York, NY | Abr 21, 2026 | Okt 1, 2026 | Sertipikado |
| Managing Director, Australian Equity Sales - Americas | $175,000 Antas II | New York, NY | Abr 21, 2026 | Okt 1, 2026 | Sertipikado |
| Managing Director, Australian Equity Sales Manager | $175,000 E-3 · Antas II | New York, NY | Nob 5, 2025 | Dis 1, 2025 | Sertipikado |
| Second Year Banking Associate | $180,000 Antas III | New York, NY | Ago 19, 2025 | Set 8, 2025 | Sertipikado |
| Vice President, Biotechnology Equity Research | $150,000 Antas III | New York, NY | Hul 8, 2025 | Okt 1, 2025 | Sertipikado |
| Banking Analyst 1 | $100,000 Antas I | New York, NY | Abr 8, 2025 | Okt 1, 2025 | Sertipikado |
| Banking Analyst 1 | $100,000 Antas I | New York, NY | Abr 8, 2025 | Okt 1, 2025 | Sertipikado, pagkatapos ay tinanggal |
| Banking Analyst 2 | $110,000 Antas I | New York, NY | Abr 8, 2025 | Okt 1, 2025 | Sertipikado |
| Australian Institutional Equity Sales (Americas) | $188,880 E-3 · Antas II | New York, NY | Ene 8, 2025 | Mar 1, 2025 | Sertipikado |
| Vice President - Australian Product Sales | $145,000 E-3 · Antas II | New York, NY | Set 26, 2024 | Dis 1, 2024 | Sertipikado |
| Director, Australian Equities | $175,000 E-3 · Antas III | New York, NY | Set 26, 2023 | Dis 1, 2023 | Sertipikado |
| Director, Salesperson | $120,000 H-1B1 (Chile) · Antas III | Miami, FL | Set 26, 2023 | Dis 1, 2023 | Sertipikado |
| Senior Research Associate (Biotechnology) | $135,000 Antas III | New York, NY | Hun 12, 2023 | Ago 31, 2023 | Sertipikado |
| Investment Banking Analyst | $100,000 Antas I | New York, NY | Mar 20, 2023 | Set 2, 2023 | Sertipikado, pagkatapos ay tinanggal |
| Investment Banking Analyst | $135,000 Antas I | New York, NY | Mar 16, 2023 | Ago 23, 2023 | Sertipikado |
| Investment Banking Analyst | $100,000 Antas I | New York, NY | Mar 7, 2023 | Ago 20, 2023 | Sertipikado, pagkatapos ay tinanggal |
| Associate, Australian Desk Salesperson | $110,000 E-3 · Antas I | New York, NY | Mar 6, 2023 | Abr 1, 2023 | Sertipikado |
| Associate, Australian Desk Salesperson | $110,000 Antas I | New York, NY | Mar 6, 2023 | Ago 20, 2023 | Sertipikado |
| Analyst (3rd Year) | $120,000 Antas II | New York, NY | May 6, 2022 | May 31, 2022 | Sertipikado, pagkatapos ay tinanggal |
| Director, Investment Banking | $250,000 Antas II | New York, NY | Mar 3, 2022 | Hun 1, 2022 | Sertipikado, pagkatapos ay tinanggal |
| Analyst (2nd Year) | $105,000 Antas II | Boston, MA | Nob 5, 2021 | Nob 29, 2021 | Sertipikado, pagkatapos ay tinanggal |
Ang mga sahod ay ang mababang dulo ng alok na sweldo sa bawat aplikasyon, na isinalin sa taunang halaga; ginagamit lamang ng istatistika ang mga sertipikadong full-time na aplikasyon. Ang LCA ay hindi pag-apruba ng visa at maaaring saklawin ng isang LCA ang ilang posisyon. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (pinakabagong desisyon: Hun 30, 2026).